- Home
- SPTN vs CRMD Comparison
SPTN vs CRMD Comparison
Compare SPTN & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- CRMD
- Stock Information
- Founded
- SPTN 1917
- CRMD 2006
- Country
- SPTN United States
- CRMD United States
- Employees
- SPTN 17000
- CRMD N/A
- Industry
- SPTN Food Distributors
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- CRMD Health Care
- Exchange
- SPTN Nasdaq
- CRMD Nasdaq
- Market Cap
- SPTN 630.9M
- CRMD 753.6M
- IPO Year
- SPTN N/A
- CRMD 2010
- Fundamental
- Price
- SPTN $18.69
- CRMD $10.15
- Analyst Decision
- SPTN Hold
- CRMD Strong Buy
- Analyst Count
- SPTN 1
- CRMD 6
- Target Price
- SPTN $20.00
- CRMD $15.67
- AVG Volume (30 Days)
- SPTN 248.1K
- CRMD 1.5M
- Earning Date
- SPTN 02-12-2025
- CRMD 03-11-2025
- Dividend Yield
- SPTN 4.71%
- CRMD N/A
- EPS Growth
- SPTN 9.92
- CRMD N/A
- EPS
- SPTN 1.33
- CRMD N/A
- Revenue
- SPTN $9,532,883,000.00
- CRMD $12,262,234.00
- Revenue This Year
- SPTN N/A
- CRMD N/A
- Revenue Next Year
- SPTN $2.15
- CRMD $246.41
- P/E Ratio
- SPTN $14.06
- CRMD N/A
- Revenue Growth
- SPTN N/A
- CRMD 41184.20
- 52 Week Low
- SPTN $17.30
- CRMD $2.89
- 52 Week High
- SPTN $23.00
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- SPTN 56.59
- CRMD 40.80
- Support Level
- SPTN $17.77
- CRMD $11.90
- Resistance Level
- SPTN $18.66
- CRMD $12.67
- Average True Range (ATR)
- SPTN 0.40
- CRMD 0.73
- MACD
- SPTN 0.11
- CRMD -0.27
- Stochastic Oscillator
- SPTN 96.19
- CRMD 2.12
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.